ADVERTISEMENT

Investment

Calico and AbbVie advance antiaging efforts

by Ryan Cross
June 30, 2018 | APPEARED IN VOLUME 96, ISSUE 27

09627-ISRIB.jpg

AbbVie is boosting its collaboration with the secretive antiaging company Calico, which is backed by Alphabet, Google’s parent company. Both companies will contribute $500 million more to drug discovery efforts that began in 2014. A scientific publication (eLife 2018, DOI: 10.7554/eLife.32733) indicates that the duo is working with a molecule called ISRIB, integrated stress response inhibitor. Other groups previously demonstrated that ISRIB enhances memory and appears to reverse the effects of traumatic brain injury in mice.

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment